Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

[Physiological functions of sigma-1 receptors and its relation to psychic dependence].

Mori T, Yoshizawa K, Shibasaki M, Suzuki T.

Nihon Arukoru Yakubutsu Igakkai Zasshi. 2012 Dec;47(6):279-86. Review. Japanese.

PMID:
23461216
2.

Sigma-1 receptor: the novel intracellular target of neuropsychotherapeutic drugs.

Hayashi T.

J Pharmacol Sci. 2015 Jan;127(1):2-5. doi: 10.1016/j.jphs.2014.07.001. Epub 2014 Dec 9. Review.

3.

Regulation of sigma-1 receptors and endoplasmic reticulum chaperones in the brain of methamphetamine self-administering rats.

Hayashi T, Justinova Z, Hayashi E, Cormaci G, Mori T, Tsai SY, Barnes C, Goldberg SR, Su TP.

J Pharmacol Exp Ther. 2010 Mar;332(3):1054-63. doi: 10.1124/jpet.109.159244. Epub 2009 Nov 25.

4.

Expression of a truncated form of the endoplasmic reticulum chaperone protein, σ1 receptor, promotes mitochondrial energy depletion and apoptosis.

Shioda N, Ishikawa K, Tagashira H, Ishizuka T, Yawo H, Fukunaga K.

J Biol Chem. 2012 Jul 6;287(28):23318-31. doi: 10.1074/jbc.M112.349142. Epub 2012 May 22.

5.

The sigma-1 receptor chaperone as an inter-organelle signaling modulator.

Su TP, Hayashi T, Maurice T, Buch S, Ruoho AE.

Trends Pharmacol Sci. 2010 Dec;31(12):557-66. doi: 10.1016/j.tips.2010.08.007. Epub 2010 Oct 1.

7.

Sigma-1 receptor chaperone and brain-derived neurotrophic factor: emerging links between cardiovascular disease and depression.

Hashimoto K.

Prog Neurobiol. 2013 Jan;100:15-29. doi: 10.1016/j.pneurobio.2012.09.001. Epub 2012 Oct 5. Review.

PMID:
23044468
8.

Could sigma receptor ligands be a treatment for methamphetamine addiction?

Rodvelt KR, Miller DK.

Curr Drug Abuse Rev. 2010 Sep;3(3):156-62. Review.

PMID:
21054260
9.

Sigma-1 receptor chaperone at the ER-mitochondrion interface mediates the mitochondrion-ER-nucleus signaling for cellular survival.

Mori T, Hayashi T, Hayashi E, Su TP.

PLoS One. 2013 Oct 18;8(10):e76941. doi: 10.1371/journal.pone.0076941. eCollection 2013.

10.

Sigma (σ) receptors as potential therapeutic targets to mitigate psychostimulant effects.

Matsumoto RR, Nguyen L, Kaushal N, Robson MJ.

Adv Pharmacol. 2014;69:323-86. doi: 10.1016/B978-0-12-420118-7.00009-3. Review.

PMID:
24484982
11.

Suppressive effects of 4-phenylbutyrate on the aggregation of Pael receptors and endoplasmic reticulum stress.

Kubota K, Niinuma Y, Kaneko M, Okuma Y, Sugai M, Omura T, Uesugi M, Uehara T, Hosoi T, Nomura Y.

J Neurochem. 2006 Jun;97(5):1259-68. Epub 2006 Mar 15.

12.

The effects of sigma, PCP, and opiate receptor ligands in rats trained with ibogaine as a discriminative stimulus.

Helsley S, Filipink RA, Bowen WD, Rabin RA, Winter JC.

Pharmacol Biochem Behav. 1998 Feb;59(2):495-503.

PMID:
9477000
13.

Sigma-1 receptor ligands: potential in the treatment of neuropsychiatric disorders.

Hayashi T, Su TP.

CNS Drugs. 2004;18(5):269-84. Review.

PMID:
15089113
14.

Conversion of psychological stress into cellular stress response: roles of the sigma-1 receptor in the process.

Hayashi T.

Psychiatry Clin Neurosci. 2015 Apr;69(4):179-91. doi: 10.1111/pcn.12262. Epub 2015 Feb 16. Review.

15.

Intracellular dynamics of sigma-1 receptors (sigma(1) binding sites) in NG108-15 cells.

Hayashi T, Su TP.

J Pharmacol Exp Ther. 2003 Aug;306(2):726-33. Epub 2003 May 2.

18.
20.

The sigma-1 receptor antagonist PB212 reduces the Ca²⁺-release through the inositol (1, 4, 5)-trisphosphate receptor in SK-N-SH cells.

Gasparre G, Abate C, Berardi F, Cassano G.

Eur J Pharmacol. 2012 Jun 5;684(1-3):59-63. doi: 10.1016/j.ejphar.2012.03.021. Epub 2012 Mar 23.

PMID:
22465185

Supplemental Content

Support Center